High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastoma

Glioblastoma Multiforme (GBM) is the most common primary brain tumour in adults, yet survival outcomes remain poor. First line treatment is well established but with disease recurrence almost inevitable, improving prognosis is challenging. With the aim of personalising therapy at recurrence we have...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Taylor, Jessica, Yu, Kenny, Pathmanaban, Omar, Beyit, Deniz, Dutko-Gwozdz, Joanna, Benson, Rod, Griffiths, Gareth, McBain, Catherine, Peers, Ian, Ceuppens, Peter, Kamaly-asl, Ian, Bigger, Brian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5791612/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox237.024
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia